Xiuzheng Pharmaceutical Group (修正集团), established in 1995, is a modernized large-scale private pharmaceutical enterprise with total assets of 17 billion yuan ($2.53 billion) and an operating revenue of 63.6 billion yuan by the end of 2016.
Its businesses include scientific research, production and marketing of patent medicine, and chemical and biological pharmacy, along with medicine chain operation and standard cultivation of Chinese medicinal materials.
Having achieved rapid development, the group ranked No 53 in the list of "China's Top 500 Private Enterprises" in 2016.